Alvotech ( ($ALVO) ) has shared an announcement. On November 10, 2025, Alvotech announced that the UK High Court ruled in its favor, rejecting an ...
Scotiabank analyst Louise Chen initiated coverage of Regeneron (REGN) with a Sector Perform rating and $650 price target Published first on TheFly ...
Williams & Connolly, a General Litigation Department of the Year finalist, notched several victories before the U.S. Supreme ...
New details have emerged about what Regeneron is planning for the Saratoga Springs site it acquired last year.
Global drug stocks rally as the FDA names Richard Pazdur, its top cancer drug regulator, as the head of its influential ...